Tag: covid-19 vaccine trials
One of the most promising COVID-19 vaccine trials has been halted; after one of its U.K participants developed a “potentially unexplained illness”. The vaccine was developed by the University of Oxford in partnership with AstraZeneca, and is currently being trialled in South Africa, Brazil, the UK and the US. Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand joins CNBC Africa for more.
It’s been almost three weeks since South Africa’s first COVID-19 vaccine trials began, we will be unpacking more on the progress of these trials as well as the latest emerging evidence brought to the attention of the World Health Organization regarding the airborne transmission of COVID-19. Joining CNBC Africa for more is Shabir Madhi, Professor of Vaccinology at the University of Witwatersrand.